Efficiency of the APTIMA® HPV Assay for detection of HPV RNA and DNA targets

This publication has 10 references indexed in Scilit:

• Comparison of Predictors for High-Grade Cervical Intraepithelial Neoplasia in Women with Abnormal Smears
  Cancer Epidemiology, Biomarkers & Prevention, 2008
• Comparison of the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay for detection of high-risk human papillomavirus in women with abnormal PAP smear
  Journal of Virological Methods, 2008
• Comparison of the Digene Hybrid Capture 2 Assay and Roche AMPLICOR and LINEAR ARRAY Human Papillomavirus (HPV) Tests in Detecting High-Risk HPV Genotypes in Specimens from Women with Previous Abnormal Pap Smear Results
  Journal of Clinical Microbiology, 2007
• Population‐based study of screening test performance indices of three human papillomavirus DNA tests
  Journal of Medical Virology, 2007
• Integration of high‐risk human papillomavirus: a key event in cervical carcinogenesis?
  The Journal of Pathology, 2007
• Agreement between the AMPLICOR Human Papillomavirus Test and the Hybrid Capture 2 Assay in Detection of High-Risk Human Papillomavirus and Diagnosis of Biopsy-Confirmed High-Grade Cervical Disease
  Journal of Clinical Microbiology, 2007
• Overview of the European and North American studies on HPV testing in primary cervical cancer screening
  International Journal of Cancer, 2006
• Comparison of the Digene HC2 Assay and the Roche AMPLICOR Human Papillomavirus (HPV) Test for Detection of High-Risk HPV Genotypes in Cervical Samples
  Journal of Clinical Microbiology, 2006
• Performance of the Roche AMPLICOR® Human papillomavirus (HPV) test in prediction of cervical intraepithelial neoplasia (CIN) in women with abnormal PAP smear
  Gynecologic Oncology, 2005
• The epidemiology of human papillomavirus infections
  Published by Elsevier ,2005